Tech Company Financing Transactions
Signature Genomic Laboratories Funding Round
Amidzad Partners participated in a venture round for Signature Genomic Laboratories. The round was announced by the company on 1/23/2008.
Transaction Overview
Company Name
Announced On
1/23/2008
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Amidzad Partners (David Parker)
Proceeds Purpose
"We are very excited about Ampersand partnering with us because they will allow Signature to position itself favorably in this growing market," said Dr. Shaffer. "With both Ampersand's and Providence's experience in the clinical laboratory services industry, we are in an excellent position to identify new partners for strategic growth."
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2820 North Astor Street
Spokane, WA 99207
USA
Spokane, WA 99207
USA
Phone
Website
Email Address
Overview
Signature Genomic Laboratories specializes in microarray technology, and is the leading innovator in diagnostic microarray testing, providing the fastest, most thorough, and most objective chromosome analysis available. Health care providers should consider ordering microarray analysis for patients for whom they routinely order conventional karyotyping, subtelomeric FISH, and/or single-locus FISH.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lisa Shaffer
Browse more venture capital transactions:
Prev: 1/23/2008: SmartTurn venture capital transaction
Next: 1/23/2008: Box venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs